These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

58 related items for PubMed ID: 2283305

  • 41. [Circulating immune complex cholesterol as a biochemical marker of coronary atherosclerosis].
    Kalenich OS, Tertov VV, Novikov ID, Vorob'eva EG, Perova NV, Metel'skaia VA, Pomerantsev EV, Liakishev AA, Ruda MIa, Orekhov AN.
    Kardiologiia; 1991 Feb; 31(2):42-4. PubMed ID: 2041290
    [Abstract] [Full Text] [Related]

  • 42. [Statistics of coronary sclerosis].
    ZSCHOCH H.
    Zentralbl Allg Pathol; 1957 Jul 05; 96(7-8):321-30. PubMed ID: 13478120
    [No Abstract] [Full Text] [Related]

  • 43. A burden of proof study on alcohol consumption and ischemic heart disease.
    Carr S, Bryazka D, McLaughlin SA, Zheng P, Bahadursingh S, Aravkin AY, Hay SI, Lawlor HR, Mullany EC, Murray CJL, Nicholson SI, Rehm J, Roth GA, Sorensen RJD, Lewington S, Gakidou E.
    Nat Commun; 2024 May 14; 15(1):4082. PubMed ID: 38744810
    [Abstract] [Full Text] [Related]

  • 44. Reference distributions for apolipoproteins AI and B and B/AI ratios: comparison of a large cohort to the world's literature.
    Ritchie RF, Palomaki GE, Neveux LM, Ledue TB, Marcovina S, Navolotskaia O.
    J Clin Lab Anal; 2006 May 14; 20(5):218-26. PubMed ID: 16960899
    [Abstract] [Full Text] [Related]

  • 45. Coronary sclerosis risk factors in males with special reference to lipoproteins and apoproteins: establishing an index.
    Kawanishi M, Nakamoto A, Konemori G, Horiuchi I, Kajiyama G.
    Hiroshima J Med Sci; 1990 Sep 14; 39(3):61-4. PubMed ID: 2283305
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Lipids, lipoproteins and apolipoproteins among turks, and impact on coronary heart disease.
    Onat A.
    Anadolu Kardiyol Derg; 2004 Sep 14; 4(3):236-45. PubMed ID: 15355827
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Lipids, lipoproteins and apolipoproteins among turks, and impact on coronary heart disease.
    Onat A.
    Anadolu Kardiyol Derg; 2004 Sep 14; 4(3):236-45. PubMed ID: 15355827
    [Abstract] [Full Text] [Related]

  • 53. [Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks].
    Onat A, Ozhan H, Can G, Hergenç G, Karabulut A, Albayrak S.
    Anadolu Kardiyol Derg; 2007 Jun 14; 7(2):128-33. PubMed ID: 17513206
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Coronary sclerosis risk factors in males with special reference to lipoproteins and apoproteins: establishing an index.
    Kawanishi M, Nakamoto A, Konemori G, Horiuchi I, Kajiyama G.
    Hiroshima J Med Sci; 1990 Sep 14; 39(3):61-4. PubMed ID: 2283305
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Coronary sclerosis risk factors in males with special reference to lipoproteins and apoproteins: establishing an index.
    Kawanishi M, Nakamoto A, Konemori G, Horiuchi I, Kajiyama G.
    Hiroshima J Med Sci; 1990 Sep 14; 39(3):61-4. PubMed ID: 2283305
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [New Search]
    of 3.